Results 111 to 120 of about 1,513,260 (338)

Reciprocal contraction of antagonistic muscles in peripheral preparations, using flashing neon-lamp circuit for excitation of nerve

, 1929
Grace Briscoe, W A Leyshon
openalex   +1 more source

ANTAGONISTIC GROWTH PRINCIPLES OF SERUM AND THEIR RELATION TO OLD AGE [PDF]

, 1923
Alexis Carrel, Albert H. Ebeling
openalex   +1 more source

RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype. [PDF]

, 2019
Tumor subtype-specific metabolic reprogrammers could serve as targets of therapeutic intervention. Here we show that triple-negative breast cancer (TNBC) exhibits a hyper-activated cholesterol-biosynthesis program that is strongly linked to nuclear ...
Bold, Richard J, Borowsky, Alexander D, Cai, Demin, Chen, Hong-Wu, Chen, Xinbin, Evans, Ronald M, Fiehn, Oliver, Gao, Bei, Huang, Zenghong, Jiang, Yuqian, Kung, Hsing-Jien, Lam, Kit S, Lara, Primo N, Li, Jian Jian, Li, Jin, To, Ka-Fai, Wang, Junjian, Wu, Feng, Xu, Jianzhen, Zhao, Ruqian, Zou, Hongye, Zou, June X   +21 more
core  

Targeting renal cell carcinoma with a HIF-2 antagonist

Nature, 2016
Wen-fang Chen, Haley Hill, A. Christie, M. Kim, E. Holloman, Andrea Pavía-Jiménez, Farrah Homayoun, Yuanqing Ma, Nirav Patel, Paul C. Yell, G. Hao, Qurratulain Yousuf, Allison Joyce, I. Pedrosa, Heather Geiger, He Zhang, Jenny R Chang, K. Gardner, R. Bruick, C. Reeves, Tae Hyun Hwang, K. Courtney, E. Frenkel, Xiankai Sun, N. Zojwalla, T. Wong, Jim Rizzi, E. Wallace, J. Josey, Yang Xie, Xian-Jin Xie, Payal Kapur, R. McKay, J. Brugarolas   +33 more
semanticscholar   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

Clinical Effects of the Dichloro and Monochlorophenyl Analogues of Diamino Pyrimidine: Antagonists of Folic Acid12 [PDF]

, 1954
M. Lois Murphy, Rose Ruth Ellison, David A. Karnofsky, Joseph H. Burchenal   +3 more
openalex   +1 more source

The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist

Science, 2008
Veli-Pekka Jaakola, Mark T. Griffith, M. Hanson, V. Cherezov, E. Chien, J. R. Lane, A. IJzerman, R. Stevens   +7 more
semanticscholar   +1 more source

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

Molecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed, Lucas Mani, Muhammad Bilal Mirza, Ashtyn McAdoo, Takahito Kondo, Hidenori Tanaka, Nicole Meeks, Eben Rosenthal, Marisa Hom   +8 more
wiley   +1 more source

Observations on the effects of the folic acid antagonists, aminopterin and amethopterin, in patients with advanced neoplasms [PDF]

, 1952
Emanuel B. Schoenbach, Jacob Colsky, Ezra M. Greenspan   +2 more
openalex   +1 more source

GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type

Human Reproduction Update, 2017
C. Lambalk, F. Banga, J. Huirne, M. Toftager, A. Pinborg, R. Homburg, F. Veen, M. Wely   +7 more
semanticscholar   +1 more source